Secondary
Voyager Therapeutics
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.
Symbol
VYGR
Last Closing Price
$13.38
Effective Date
November 8, 2017
Underwriters
Morgan Stanley, Cowen
To view the prospectus for Voyager Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277